What is 4-AcO-DET?

4-AcO-DET, also known as psilacetin, is a chemical that falls under the class of tryptamines. It is a synthetic compound that is chemically similar to psilocybin, a naturally occurring psychedelic compound found in certain mushrooms.

Researchers are particularly interested in studying 4-AcO-DET because of its potentially psychoactive properties and similarity to psilocybin. The compound is structurally related to serotonin.

4 -AcO-DET is mainly used in laboratories for scientific research. Researchers want to investigate the effects on the central nervous system and explore the potential therapeutic applications. By studying the compound, researchers hope to gain insight into its pharmacological properties, mechanisms of action and interactions with various receptors in the brain.

The research on 4-AcO-DET contributes to our understanding of the neurobiology of psychedelics and their potential therapeutic applications. Scientists are exploring the potential in several areas, including neuroscience, psychology and psychiatry, with the aim of discovering new insights into the brain and developing innovative treatment methods.

4-AcO-DET 20mg Pellets are a research chemical product containing 4-AcO-DET, a synthetic tryptamine compound. Each pellet contains 20 milligrams (mg) of 4-AcO-DET, carefully formulated for accurate dosing and research purposes.

Ingredients:
– 4-AcO-DET: 20mg
– Inactive ingredients: Microcrystalline cellulose, lactose, magnesium stearate, colloidal silicon dioxide, and other pharmaceutical excipients.

Product Features:
– Accurate Dosage: Each pellet contains a precisely measured 20mg dose of 4-AcO-DET, ensuring consistent and reliable dosing for research purposes.
– Convenient Formulation: The pellets are designed for easy handling and administration, allowing for precise research experimentation.
– High Purity: 4-AcO-DET used in the pellets is of research-grade quality, meeting strict quality standards for scientific investigations.
– Psychedelic Effects: 4-AcO-DET is known for its potential psychedelic properties, including altered states of consciousness, visual distortions, and potential entheogenic experiences.

Usage Instructions:
– Researchers should follow appropriate safety protocols and guidelines when handling and conducting experiments with 4-AcO-DET.
– Dosage and administration methods should be determined based on the specific research objectives and in accordance with ethical and legal considerations.

Safety Precautions:
– 4-AcO-DET is a potent research compound and should only be used by qualified researchers in controlled laboratory settings.
– Researchers should adhere to all applicable laws, regulations, and institutional guidelines regarding the handling, storage, and disposal of 4-AcO-DET.
– Proper personal protective equipment (PPE) should be worn when handling 4-AcO-DET to minimize the risk of exposure.
– Researchers should have access to appropriate safety equipment, emergency protocols, and medical assistance in case of accidental exposure or adverse reactions.

How did 4-AcO-DET come about?

4-AcO-DET, also known as psilacetin, is a chemical belonging to the tryptamine family. It was first synthesized and studied by a team of scientists in the early 1990s. The compound was created as part of ongoing research into the chemical structure and properties of psychoactive substances.

The discovery and development of 4-AcO-DET were driven by the desire to investigate the effects of new compounds on the human brain and behavior. The first studies on 4-AcO-DET focused on its chemical composition, synthesis methods, and physical properties. Researchers were intrigued by its similarity to psilocybin, as they hypothesized that it might have similar psychoactive effects. The compound was subjected to rigorous laboratory testing and analysis to determine its potency, stability and potential applications.

As research progressed, scientists began investigating the effects of 4-AcO-DET in animal models to better understand its pharmacological properties. They investigated its interactions with various receptors in the brain, with the aim of elucidating the compound’s mechanism of action and potential therapeutic applications.